Dublin, Feb. 13, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Oligonucleotide Synthesis Market to Reach $19.9 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Oligonucleotide Synthesis estimated at US$6.1 Billion in the year 2022, is projected to reach a revised size of US$19.9 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2022-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is projected to record a 17.6% CAGR and reach US$8.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Synthesized Oligonucleotides segment is readjusted to a revised 15.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 21.5% CAGR
The Oligonucleotide Synthesis market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 21.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 13.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2030.
Select Competitors (Total 41 Featured) -
- ATDBio Ltd.
- Bio-Synthesis Inc.
- Eurogentec
- GE Healthcare Life Sciences
- GeneDesign, Inc.
- GenScript Biotech Corporation
- Integrated DNA Technologies (IDT), Inc.
- LGC Biosearch Technologies
- Merck KgaA
- Nitto Denko Avecia Inc.
- Thermo Fisher Scientific, Inc.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $6.1 Billion |
| Forecasted Market Value (USD) by 2030 | $19.9 Billion |
| Compound Annual Growth Rate | 15.9% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Growing Demand for Oligonucleotide-based Drugs to Boost the Oligonucleotide Synthesis Market
- Increased Pharma R&D to Spur the Market Growth
- FDA-Approved Oligonucleotide-based Drugs Promise Huge Potential for Market Growth
- Recent Approval of Exondys 51 and Nusinersen Aids in Treatment of Inherited Diseases
- Oligonucleotide Drugs Aid Effective Treatment of Neurodegenerative Disorders
- Inotersen - The Second FDA Approved Drug for Polyneuropathy, Following Onpattro
- Market Outlook and Advancements in Antisense Drugs
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/w87ong
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
